WASHINGTON, DC: The U.S. Chamber of Commerce’s U.S.-India Business Council (USIBC) today announced Vice Chairs for its 2021 Global Board of Directors, strengthening its leadership team as the Council engages a new U.S. administration and advocates for stronger U.S.-India commercial ties in an increasingly complex world.

“I’m pleased to see the U.S.-India Business Council elevate as Vice Chairs these captains of industry and forward-thinking business leaders,” said Vijay Advani, USIBC Board of Directors Chairman and Executive Chairman, Nuveen. “Their perspectives will be invaluable as USIBC charts a path forward in the post-pandemic era and continues its work to deepen the U.S.-India partnership.”

Effective immediately, Milind Pant, CEO, Amway; Kiran Mazumdar-Shaw, Executive Chairperson, Biocon; and Edward Knight, Vice Chair, Nasdaq will join the Board’s leadership team as Vice Chairs.

“I am honored to step into this new role as a Vice Chair for the U.S.-India Business Council’s Board of Directors,” said Milind Pant, CEO, Amway. “During my time at Amway, I’ve greatly valued the USIBC and its role in helping American companies operating in India. I look forward to the continued engagement in strengthening the U.S.-India bilateral relationship in this role.”

As Vice Chairs, Pant, Mazumdar-Shaw and Knight will work with USIBC President Nisha Biswal and the Council’s policy directors to elevate priorities in critical sectors and lead meetings between industry and government. They will work to amplify the voice of industry on international trade and investment issues and emphasize the critical role that businesses can play in strengthening democratic institutions and combatting the global pandemic.

“As the world recovers from the global pandemic, the economic relationship between the United States and India has never been more important to Nasdaq and its listed companies. The U.S.-India Business Council is a vital link between the two business communities and a proven facilitator of a productive dialog between the U.S. and Indian Governments,” said Edward Knight, Vice Chair, Nasdaq. “I am honored to serve as Vice Chair and work even more closely with USIBC President Nisha Biswal, the excellent professional staff she has assembled, and my fellow Board members.”

Kiran Mazumdar-Shaw, Executive Chairperson, Biocon, concurred, saying, “I am honoured to serve as a Vice Chair at the USIBC Board of Directors. USIBC has been committed to enhancing US-India bilateral trade and in my new role, I look forward to forging collaborative initiatives in Pharma & Healthcare in the area of research, innovation and skill development between our two nations. The pandemic has provided a unique opportunity for robust engagement between our two nations that can lead to knowledge sharing in digital healthcare, medical technologies and IP led drug and vaccine innovation to deliver healthcare solutions that can boost mutually beneficial bilateral trade.”